| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Delaware Street Capital Master Fund, L.P. last filed a Form 4 in October 2018, as 10% Owner at ZVRA.
At the last filing, the largest reported position was 4,095,914 shares of ZVRA. Net of sales, the ZVRA filings show accumulation of 2,630,171 shares.
Delaware Street Capital Master Fund, L.P. has 3 Form 4 filings on record from September 2017 to October 2018, all as 10% Owner at Zevra Therapeutics (ZVRA), 2017–2018.
The 5 reported transactions were 5 open-market purchases.
Counted by filing, the open-market trades come to 3 purchases worth about $8.3M and no sales.
The largest open-market purchase was 2,000,000 shares of ZVRA at an average $3.00 on October 5, 2018, about $6.0M.
Shares as reported in the last Form 4 for each company; the most recent is from October 2018. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.